Miami Cancer Institute’s partnership with the Memorial Sloan Kettering Cancer Alliance combined with the advanced technology utilized by our genomic center creates a clinical trials program unmatched by any other in South Florida and among the best in the nation.
Clinical trials offer hope.
Miami Cancer Institute provides you with access to cutting-edge and innovative clinical trials, facilitating the availability of promising new drugs and therapies to treat your cancer. Our clinical research program is organized around disease-specific research groups. Under the direction of internationally renowned oncology researcher Miguel Villalona Calero, M.D., deputy director and chief scientific officer, our researchers focus on precision medicine, conducting patient-centered studies that consider your variability in genes, environment and lifestyle. Detailed genetic and other molecular information about your cancer is used to deploy effective, personalized remedies to treat it.
Clinical trials are at the heart of all medical advances.
Only through clinical research can we gain insights into new ways to prevent and detect cancer and learn about the safety and efficacy of new therapies and medicines.
Here are frequently asked questions and answers about clinical trials: (List these questions only and then link to a pop-up box with the answers)
How are cancer clinical trials conducted?
Clinical trials are designed by physicians and researchers who develop an action plan (protocol) that describes the study’s objective, steps, methodologies and schedule. Doctors also evaluate criteria such as your cancer type, age, gender, medical history and current health status to determine your eligibility for participation in the study.
How do I learn more about a clinical trial?
A doctor or research nurse from the research team will provide you with important facts about the clinical trial. You will learn about its purpose, tests and procedures as well as possible risks and benefits.
How are my rights protected?
Clinical trials are conducted in accordance with strict scientific and ethical principles. Groups of experts at the national and local levels, including the Institutional Review Board (IRB) of the research organization implementing the trial, approve research studies before they begin. An IRB, which is comprised of doctors, researchers, community leaders and other consumers, protects your safety by ensuring the study is conducted fairly and you are well-informed of your rights during the study. If you choose to participate in the study, you will be asked to sign a consent form that explains the study. However, even if you sign the consent form, you may stop participating in the study at any time.
What are the benefits of participating in a clinical trial?
- You may have access to promising new therapies that doctors hope will be more effective or less toxic than the standard treatment. In many cases, these therapies are not yet available to patients outside the study.
- You can play an active role in your cancer care by expanding your treatment options.
- You will receive expert medical care during the trial and throughout your treatment.
- Your overall health is closely monitored throughout the trial.
What are some of the possible risks of participating in a clinical trial?
- Participants in randomized studies will not choose the approach they receive.
- Therapies under study are not always better than the standard care.
- New treatments may have unknown side effects or risks.
What questions should I ask before entering a clinical trial?
- What is the purpose of this study?
- How will it help me or other patients?
- What side effects might I experience?
- What other treatment options are available?
- Are there possible long-term risks?
- How will participating in this study affect my daily life?
- What are the treatments, medical tests or procedures I will undergo during the study?
- Who will oversee my care?
- How long will the study last?
- Will my health insurance cover treatments and tests I receive as part of this study?
- What kind of follow-up care will I receive after the study?